Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
One recent analysis of six years of medical records from the Department of Veterans Affairs, which reviewed the records of 2 million patients with diabetes, found that those taking a GLP-1 agonist medication had a reduced risk of developing dementia, including Alzheimers, as well as psychiatric and substance use disorders, though it also found an increased risk of gastrointestinal disorders, kidney stones, and pancreatitis
This becomes particularly important since inflammation in people with obesity may reduce blood-brain barrier integrity 28
Rajewski, P
Superior Bioavailability: Liposomal technology bypasses the absorption ceiling of standard GSH, delivering significantly higher concentrations to target cells
Another SELECT analysis looked at differences in outcomes based on patients' gender
[DOI] [PubMed] [Google Scholar] 55.Tuttle K.R., Rayner B., Lakshmanan M.C., et al
.jpg)
